Inventor · disambiguated record
Scott E. Lazerwith
Also filed as: LAZERWITH SCOTT E · LAZERWITH SCOTT EDWARD
55 granted patents·31 pending applications·626 citations·filing 2006–2024
99Inventor score
Top patents by PatentIndex Score
86 records- 0198US11680064B2Capsid inhibitors for the treatment of HIVGILEAD SCIENCES INC·Filed 2021·Granted Jun 20, 2023·9 cites·16 claims
- 0298US9216996B2Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2013·Granted Dec 22, 2015·67 cites·6 claims
- 0398US8841278B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 23, 2014·20 cites·7 claims
- 0498US8273341B2Antiviral compoundsGUO HONGYAN·Filed 2011·Granted Sep 25, 2012·47 cites·21 claims
- 0598US8088368B2Antiviral compoundsGUO HONGYAN·Filed 2010·Granted Jan 3, 2012·86 cites·23 claims
- 0697US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0797US9951043B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2014·Granted Apr 24, 2018·36 cites·34 claims
- 0897US8822430B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 2, 2014·17 cites·17 claims
- 0997US8575118B2Antiviral compoundsGUO HONGYAN·Filed 2012·Granted Nov 5, 2013·25 cites·4 claims
- 1096US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 1196US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 1296US9682084B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2015·Granted Jun 20, 2017·21 cites·20 claims
- 1396US9522912B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2015·Granted Dec 20, 2016·21 cites·53 claims
- 1495US12077537B2Capsid inhibitors for the treatment of HIVGILEAD SCIENCES INC·Filed 2023·Granted Sep 3, 2024·2 cites·8 claims
- 1595US11773122B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·4 cites·38 claims
- 1695US11420974B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Aug 23, 2022·4 cites·33 claims
- 1794US9732092B2Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2016·Granted Aug 15, 2017·11 cites·16 claims
- 1894US9663528B2Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2015·Granted May 30, 2017·11 cites·4 claims
- 1994US9630978B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2016·Granted Apr 25, 2017·10 cites·24 claims
- 2094US9511056B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 6, 2016·7 cites·9 claims
- 2194US8884030B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Nov 11, 2014·29 cites·18 claims
- 2293US10836769B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·6 cites·53 claims
- 2393US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 2493US10035809B2Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2017·Granted Jul 31, 2018·10 cites·3 claims
- 2593US8524764B2Inhibitors of Flaviviridae virusesCANALES EDA·Filed 2011·Granted Sep 3, 2013·29 cites·20 claims
- 2692US10098886B2Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamideGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·10 cites·19 claims
- 2792US8536187B22,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infectionsCANALES EDA·Filed 2009·Granted Sep 17, 2013·25 cites·23 claims
- 2891US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 2990US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 3090US8513298B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2011·Granted Aug 20, 2013·14 cites·2 claims
- 3188US10689399B2Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2018·Granted Jun 23, 2020·2 cites·4 claims
- 3288US9981955B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted May 29, 2018·2 cites·20 claims
- 3388US8569302B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2010·Granted Oct 29, 2013·14 cites·20 claims
- 3487US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 3587US9795602B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2016·Granted Oct 24, 2017·4 cites·18 claims
- 3687US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3786US9321753B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Apr 26, 2016·8 cites·19 claims
- 3884US9421214B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2014·Granted Aug 23, 2016·4 cites·35 claims
- 3983US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 4082US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 4182US12030904B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 4282US8741946B2Inhibitors of flaviviridae virusesWATKINS WILLIAM J·Filed 2012·Granted Jun 3, 2014·9 cites·11 claims
- 4382US8044052B2Biaryl ether urea compoundsPFIZER·Filed 2007·Granted Oct 25, 2011·8 cites·10 claims
- 4480US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 4578US2023087744A1Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 4677US12448400B2KRAS G12D modulating compoundsGILEAD SCIENCES INC·Filed 2024·Granted Oct 21, 2025·0 cites·15 claims
- 4777US11963967B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Apr 23, 2024·0 cites·51 claims
- 4876US12473314B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 4975US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 5075US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott E. Lazerwith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →